Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Assets (2020 - 2025)

Agilon Health (AGL) has disclosed Assets for 6 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets fell 26.68% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 26.68%, and an annual FY2025 reading of $1.3 billion, down 26.68% over the prior year.
  • Assets was $1.3 billion for Q4 2025 at Agilon Health, down from $1.6 billion in the prior quarter.
  • Across five years, Assets topped out at $2.2 billion in Q1 2023 and bottomed at $574.0 million in Q1 2021.
  • Average Assets over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest move saw Assets skyrocketed 255.37% in 2021, then decreased 26.68% in 2025.
  • Year by year, Assets stood at $1.6 billion in 2021, then increased by 7.01% to $1.7 billion in 2022, then rose by 2.56% to $1.7 billion in 2023, then fell by 0.4% to $1.7 billion in 2024, then decreased by 26.68% to $1.3 billion in 2025.
  • Business Quant data shows Assets for AGL at $1.3 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.9 billion in Q1 2025.